PK Basics

Mastering Non-Compartmental Analysis (NCA): Key Parameters Explained

Pharazi.ai TeamMarch 20, 20269 min read

What is Non-Compartmental Analysis (NCA)?

NCA is the universally recognized gold standard for regulatory submissions to the FDA and EMA. It relies purely on algebraic calculations and statistical moment theory — making no assumptions about distribution mechanics.

Unlike compartmental modeling, NCA derives parameters directly from raw concentration-time data points using integral calculus (area under the curve).

The Three Pillars of NCA Parameters

Maximum Concentration and Time to Peak

$C_{ma x}$ — Highest measured plasma concentration (no calculation needed — find the max value)
$T_{ma x}$ — Time at which $C_{ma x}$ occurs

Immediate-release tablets:

T_{ma x}

0.5–2 hours. Sustained-release:

T_{ma x}

pushed further out.

Area Under the Curve

The most critical exposure metric. Calculated via the Linear Trapezoidal Rule:

A U C = \sum (\frac{C _{1} + C _{2}}{2}) im es (t_{2} - t_{1})

Variants:

A U C_{0 - a u}

(steady state) and

A U C_{0 - \infty}

(theoretical infinity).

Clearance and Volume of Distribution

Derived downstream from AUC:

IV dose:

C L = \frac{e x t D ose _{I V}}{A U C _{0 - \infty}}

Oral dose (apparent clearance):

\frac{C L}{F} = \frac{e x t D ose _{O r a l}}{A U C _{0 - \infty}}

Terminal-phase volume:

V_{z} = \frac{C L}{λ _{z}}

Statistical Moment Theory: AUMC and MRT

The Mean Residence Time (MRT) measures how long a drug molecule spends in the body:

M R T = \frac{A U M C _{0 - \infty}}{A U C _{0 - \infty}}

MRT is an incredibly powerful metric for comparing sustained-release vs. immediate-release formulations.

The Primary Vulnerability of NCA

Terminal Phase Selection is NCA's Achilles heel. If the wrong trailing data points are included in the terminal regression,

λ_{z}

corrupts — cascading errors into half-life, AUC extrapolation, and clearance.

Always verify the

R^{2}

fit of the terminal slope manually.

Try It on Pharazi.ai

Use the NCA Module Calculator to compute

A U C

A U M C

C L

V_{z}

, and

M R T

from your concentration-time arrays.

References

Gabrielsson J, Weiner D. Pharmacokinetic and Pharmacodynamic Data Analysis. 5th ed.
FDA. Guidance for Industry: Bioanalytical Method Validation. 2018.

NCApharmacokineticsAUCCmaxclearancetrapezoidal rulemoment theory

PK Basics

Absolute vs. Relative Bioavailability: Understanding the First-Pass Effect

Understand drug bioavailability (F), AUC comparisons, extravascular administration hurdles, and the devastating First-Pass Effect.

PK Basics

Linear vs. Non-Linear Pharmacokinetics: Michaelis-Menten Explained

Explore the critical threshold where linear PK mathematics fail. Understand Michaelis-Menten kinetics, zero-order elimination, and drugs with unpredictable half-lives.

All articles

Mastering Non-Compartmental Analysis (NCA): Key Parameters Explained

What is Non-Compartmental Analysis (NCA)?

The Three Pillars of NCA Parameters

Maximum Concentration and Time to Peak

Area Under the Curve

Clearance and Volume of Distribution

Statistical Moment Theory: AUMC and MRT

The Primary Vulnerability of NCA

Try It on Pharazi.ai

References

Related Articles

Absolute vs. Relative Bioavailability: Understanding the First-Pass Effect

Linear vs. Non-Linear Pharmacokinetics: Michaelis-Menten Explained